UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M‐proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)
Jenny Bird, Eric Low(Myeloma UK), Ingemar Turesson(Spanish Head & Neck Cancer Cooperative Group), Anders Waage(St Olav's University Hospital), Mark T. Drayson(Institute of Immunology), Nina Gulbrandsen(Oslo University Hospital), Henrik Gregersen(Aalborg University Hospital), Richard Soutar(NHS Greater Glasgow and Clyde), Robert Beetham(Frenchay Hospital), Judith Behrens(National Health Service), Jan Westin(Spanish Head & Neck Cancer Cooperative Group), Shirley D’Sa(University College Hospital)
Cited by 137
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
|New England Journal of Medicine|2003|1.8k